It is important to cure diseases and enhance health, therefore, researching into current medical treatments and drugs must have proper investment. Though governments and individuals benefit if health is improved, private companies should be responsible for investigation funds. In this essay, I will argue why I believe pharmaceutical enterprises must be held accountable for new medical developments.
In the last couple centuries, humans have experienced a dramatic increase of life expectancy as a consequence of improved medical treatments. People take medicine for granted, but in the past, drugs were not as developed as they are today. Moreover, with the discovery of new diseases every day, the importance of research and development becomes a priority. Take for example a complicated condition such as cancer, whether government subsidizes its treatment or private insurance takes over a patient’s care, it all comes down to improved drugs in order to ease recovery.
Consequently, funding for investigative projects must come from private capital. Furthermore, companies should prioritize innovation to ensure progress in medical treatments. While pharmaceutical companies compete in the marketplace, governments should serve as observers so that individuals are as protected as possible from the abuses of companies holding a dominant position. For instance, the search for a cure for a serious disease like AIDS, the auto-immune deficiency syndrome, needs to be proactively imposed by governments by incentivizing large companies with tax-cuts and long-term help. Ultimately, patients should be given these treatments to live their life with dignity.
To conclude, humans evolve continuously and new diseases are discovered every day. Therefore, research becomes an essential part of medical treatment because human well-being is not a static feature. In addition to this, the pharmaceutical industry benefits largely from private projects because the market dynamics are based upon competition. Lastly, the greater the investment in research, the better the chance of successfully developing new drugs to improve health.
It is
important
to cure
diseases
and enhance health,
therefore
, researching into
current
medical
treatments
and
drugs
must
have proper investment. Though
governments
and individuals benefit if health is
improved
,
private
companies
should be responsible for investigation funds. In this essay, I will argue why I believe pharmaceutical enterprises
must
be held
accountable for
new
medical
developments.
In the last couple centuries, humans have experienced a dramatic increase of life expectancy as a consequence of
improved
medical
treatments
.
People
take medicine for granted,
but
in the past,
drugs
were not as developed as they are
today
.
Moreover
, with the discovery of
new
diseases
every day, the importance of research and development becomes a priority. Take
for example
a complicated condition such as cancer, whether
government
subsidizes its
treatment
or
private
insurance takes over a patient’s care, it all
comes
down to
improved
drugs
in order to
ease
recovery.
Consequently
, funding for investigative projects
must
come
from
private
capital.
Furthermore
,
companies
should prioritize innovation to ensure progress in
medical
treatments
. While pharmaceutical
companies
compete in the marketplace,
governments
should serve as observers
so
that individuals are as protected as possible from the abuses of
companies
holding a dominant position.
For instance
, the search for a cure for a serious
disease
like AIDS, the auto-immune deficiency syndrome, needs to be
proactively
imposed by
governments
by incentivizing large
companies
with tax-
cuts
and long-term
help
.
Ultimately
, patients should be
given
these
treatments
to
live
their life with dignity.
To conclude
, humans evolve
continuously
and
new
diseases
are discovered
every day.
Therefore
, research becomes an essential part of
medical
treatment
because
human well-being is not a static feature.
In addition
to this, the pharmaceutical industry benefits
largely
from
private
projects
because
the market dynamics
are based
upon competition.
Lastly
, the greater the investment in research, the better the chance of
successfully
developing
new
drugs
to
improve
health.